Chloroquine for the 2019 novel coronavirus SARS-CoV-2

This publication has 17 references indexed in Scilit:

• Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
  Antimicrobial Agents and Chemotherapy, 2014
• Malaria
  The Lancet, 2014
• Severe Acute Respiratory Syndrome Beyond Amoy Gardens: Completing the Incomplete Legacy
  Clinical Infectious Diseases, 2013
• Drug repurposing programmes get lift off
  Nature Reviews Drug Discovery, 2012
• The role of antimalarial agents in the treatment of SLE and lupus nephritis
  Nature Reviews Nephrology, 2011
• Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
  International Journal of Antimicrobial Agents, 2007
• Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
  Antiviral Research, 2006
• New insights into the antiviral effects of chloroquine
  The Lancet Infectious Diseases, 2006
• In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
  Biochemical and Biophysical Research Communications, 2004
• A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
  New England Journal of Medicine, 2003